Neuvotion develops neurostimulation devices for people with paralysis and movement disorders.
Founded in 2019 and based in Darien, Neuvotion develops brain-body interface devices that combine artificial intelligence with targeted stimulation. Its technology is intended to help healthcare providers and rehabilitation centers treat and monitor patients with spinal cord injuries, strokes and other movement impairments. In April 2023, the company raised USD 1.25 mn from Northwell Ventures and Topspin Partners, with participation from Long Island Angel Network. The funding was intended to support hiring, clinical studies and FDA clearance for its initial product.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in